PATENT CLAIM ANALYSIS

Application Number: 15890302
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2019-02
Patent Classification: ["424", "158100"]

Abstract:
The present disclosure relates to monoclonal antibodies and antigen-binding fragments thereof that bind to human β-klotho, and pharmaceutical compositions and methods of treatment comprising the same.

Claim (Index 18):
A method of reducing body weight comprising administering to a subject in need thereof an effective amount of a pharmaceutical composition comprising an antibody or antigen-binding fragment according to  claim 1 .

Metadata:
- Claim Count in Document: 14.0
- Percentile: 88.0
- Lexical Diversity: 1.12
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14309330', '15759148', '13716526', '14163752', '15604556']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8012240972235818
- 35 USC 102 Novelty (BERT): 0.5537837526451326
- Combined Prediction Score: 0.7764800627657369
- Mean Citation Score: 468.53897
- Max Citation Score: 477.58057
- Similarity Product: 304.1016116328436

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test